Appili Therapeutics Statistics
Total Valuation
APLIF has a market cap or net worth of 2.18 million. The enterprise value is 10.17 million.
| Market Cap | 2.18M |
| Enterprise Value | 10.17M |
Important Dates
The next estimated earnings date is Thursday, June 26, 2025.
| Earnings Date | Jun 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 106.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.18 |
| PB Ratio | -0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.70 |
| EV / Sales | 113.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -23.44 |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -18.07 |
| Interest Coverage | -3.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -306.73% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 77.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 9 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.86% in the last 52 weeks. The beta is 1.08, so APLIF's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -20.86% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 47.70 |
| Average Volume (20 Days) | 60,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APLIF had revenue of 86,699 and -2.75 million in losses. Loss per share was -0.02.
| Revenue | 86,699 |
| Gross Profit | 86,699 |
| Operating Income | -6.93M |
| Pretax Income | -2.75M |
| Net Income | -2.75M |
| EBITDA | -6.92M |
| EBIT | -6.93M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 129,386 in cash and 7.84 million in debt, giving a net cash position of -7.71 million.
| Cash & Cash Equivalents | 129,386 |
| Total Debt | 7.84M |
| Net Cash | -7.71M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -9.47M |
| Book Value Per Share | -0.08 |
| Working Capital | -8.92M |
Cash Flow
In the last 12 months, operating cash flow was -432,366 and capital expenditures -1,640, giving a free cash flow of -434,006.
| Operating Cash Flow | -432,366 |
| Capital Expenditures | -1,640 |
| Free Cash Flow | -434,006 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -7,990.47% |
| Pretax Margin | -3,171.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APLIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -125.95% |
| FCF Yield | -19.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLIF has an Altman Z-Score of -70.96. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -70.96 |
| Piotroski F-Score | n/a |